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Abstract
Purpose
To develop and validate a sensitive and specific method of abscess enumeration and quan-
tification in a preclinical model of Staphylococcus aureus infection.
Methods
S. aureus infected murine kidneys were fixed in paraformaldehyde, impregnated with gado-
linium, and embedded in agar blocks, which were subjected to 3D magnetic resonance
microscopy on a 9.4T MRI scanner. Image analysis techniques were developed, which
could identify and quantify abscesses. The result of this imaging was compared with histo-
logical examination. The impact of a S. aureus Sortase A vaccination regime was assessed
using the technique.
Results
Up to 32 murine kidneys could be imaged in a single MRI run, yielding images with voxels of
about 25 μm3. S. aureus abscesses could be readily identified in blinded analyses of the kid-
neys after 3 days of infection, with low inter-observer variability. Comparison with histologi-
cal sections shows a striking correlation between the two techniques: all presumptive
abscesses identified by MRI were confirmed histologically, and histology identified no
abscesses not evident on MRI. In view of this, simulations were performed assuming that
both MRI reconstruction, and histology examining all sections of the tissue, were fully sensi-
tive and specific at abscess detection. This simulation showed that MRI provided more
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sensitive and precise estimates of abscess numbers and volume than histology, unless at
least 5 histological sections are taken through the long axis of the kidney. We used the MRI
technique described to investigate the impact of a S. aureus Sortase A vaccine.
Conclusion
Post mortem MRI scanning of large batches of fixed organs has application in the preclinical
assessment of S. aureus vaccines.
Introduction
Staphylococcus aureus is a commensal of the human skin and nares and a frequent cause of
infection in humans[1]. Virulent, often multi-resistant clones are prevalent worldwide[2].
There is currently no licensed vaccine, and S. aureus vaccine development is ongoing in an
attempt to reduce both antibiotic use driven by the organism, and its high economic and
human burden[3]. Abscess formation in internal organs is a hallmark of severe invasive disease
[4]. Established abscesses frequently require drainage, prolonged antibiotic therapy, or a com-
bination of these[5]. Therefore, preventing the initiation or early progression of abscesses is a
key goal of anti- S. aureus vaccination.
Abscess formation is a process which appears to be mediated by single organisms seeding
tissues to which they gain access within phagocytes [6, 7]. There follows a multi-step process
which includes rapid recruitment of neutrophils and macrophages to the site of bacterial prolif-
eration[8]. Thus, the formation of abscesses can be viewed in terms both of abscess number
and abscess size. Preclinical vaccine studies with S. aureus have used a mouse model involving
intravenous S. aureus administration, where bacterial count from kidneys is a measure for effi-
cacy [9]. Although recovery of viable bacteria from infected organs provides some information
about vaccine efficacy, this may not necessarily reflect abscess number or progression[10]. In
recognition of this, some studies have used in addition histological assessment of abscess for-
mation[11], a laborious technique which only examines a limited part of the kidney, depending
on the number of sections taken. These studies showed that bacterial counts increased little
after day 2 or 3 of intravenous infection, although abscess size continued to increase[10].
Several studies in mice have investigated the effects of specific S. aureus genes on abscess
formation in in vivomodels [10, 12]. In these studies, SrtA deficienct bacteria were unable to
establish abscesses, with elimination of SrtA deficient bacteria by day 15 post infection. Sortase
A, encoded by SrtA, is a membrane bound transpeptidase which is a member of the group of
microbial surface components recognizing adhesive matrix molecules (MSCRAMMs). Sortase
A recognizes LPXTG and related motifs which are present on S. aureus proteins directed for
membrane anchoring and surface display[13]. Of these LPXTG proteins, many have been
reported to have a direct role in virulence and abscess formation, such as clumping factors A
and B (ClfA, ClfB), staphylococcal protein A (SpA), serine-aspartate repeat protein D (SrdD)
and fibronectin binding proteins (FnBpA and FnBpB)[10, 14]. Therefore, effective inhibition
of sortase A by vaccines might therefore be expected to attenuate infection severity and abscess
formation.
In recent years many studies have investigated the use of various imaging techniques such
as MRI, biolumiscient imaging or PET scanning to detect bacterial infections[15–18].
Here we describe a technique to assess the formation of staphylococcal abscess(es) in murine
renal tissue, which relies on post-mortemMRI of fixed organs embedded in agar. We could
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analyse 32 kidneys in a single run. We validate the technique against histological appearances,
and illustrate its use in the assessment of efficacy of a S. aureus SrtA vaccine.
Methods
Bacteria and growth conditions
Staphylococcus aureus strain Newman wild type (wt) was obtained from Professor T. Foster,
Trinity College, Dublin. Bacteria were routinely grown on Horse Blood Agar (HBA) plates
(Oxoid, UK) or in tryptic soy broth (TSB, Oxoid, UK). Long-term storage of bacteria was at
-80°C. Strain identity was checked by colony morphology, Gram stain, mannitol fermentation,
coagulase production, DNAse activity, and sequencing of PCR products obtained across the
SpA locus (data not shown). For infection of mice, 3–4 colonies of S. aureus were picked from
HBA plates and transferred to TSB and grown overnight at 37°C, 130 rpm. This overnight
culture was subcultured 1:100 into fresh TSB and grown statically for 2.5 h at 37°C. The
culture was washed and resuspended in Phosphate Buffered Saline (PBS, Sigma Aldrich, UK)
at approximately 1×108 CFU/ml. The actual concentrations of all washed S. aureus cultures
were verified by plating and colony enumeration.
Animals
All mouse procedures were conducted in accordance to the Animal (Scientific Procedures) Act
1986 (Project licence 30/2825) and were approved by the University of Oxford Animal Care
and Ethical Review Committee. For the experiments in this study, specific pathogen free female
BALB/c mice, aged 6 weeks were obtained from Harlan Laboratories (Bicester, UK) and housed
in individually filtered cages on a normal diet.
Establishment of MRI technique in the Intravenous challenge model
Female BALB/c mice were housed in groups of 4. Twelve mice were inoculated i.v. in the lateral
tail vein with 0.1 mL (~107 CFU) bacterial suspension, prepared as above. Four mice were
injected with 0.1 mL PBS as controls. Mice were observed daily throughout the course of the
experiment. Individual mice that reached pre-defined humane endpoints as described in S1
Table before the set end of the experiment were culled immediately. On Day 3, 7 and 10 postin-
fection, mice were sacrificed (dislocation of the neck), and kidneys harvested. Viable S. aureus
per gram tissue was enumerated by spirally plating dilutions of the homogenized left kidney
on Horse Blood Agar (HBA) plates (Oxoid, UK) using Autoplate1 Automated Spiral Plater
(Advanced Instruments, Inc., Norwood, MA, USA). Plates were read using QCount Auto-
mated Colony Counter (Advanced Instruments, Inc) or manually after 24 hour incubation at
37°C. The sensitivity of detection was taken to be 100 CFU/g. The right kidney was stored in
4% paraformaldehyde (PFA, Alfa Aesar, UK) for MR processing and imaging.
Adenoviral vaccines used
DNA encoding SrtA, corresponding to amino acids 57–206 of WP_053875978.1 including an
inactivating C184A mutation [19], was human codon optimised and synthetised by Life Tech-
nologies Ltd. using GeneArt1 Gene Synthesis (www.lifetechnologies.com/UK). This antigen
construct was subcloned into a mammalian expression vector by restriction digestion and
checked by sequencing. This plasmid expresses the protein of interest behind a mammalian
leader sequence, fused at the C-terminus to a multimerising IMX313 tag[20]. pMono2 is a
mammalian expression vector constructed in Oxford University for this purpose by modifica-
tion of the vector pENTR4 (Invitrogen); construction details have been published in patent
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WO2014053861A2. From pMono2 the antigen construct was transferred into pAdHu5-DEST
(Life Technologies) using Gateway technology (Life Technologies) and the resulting construct
linearised by PacI digestion and transfected into replication-deficient adenovirus human sero-
type 5 (AdHu5) as described elsewhere [21, 22]. The control adenovirus was generated by
transfer of the expression backbone (pMono2) without any transgene into pAdHu5-DEST.
Production of SrtA protein
Recombinant SrtA-IMX313 (protein IMX501), corresponding to amino acids 60–206 of
WP_053875978.1, was expressed from E. coli cells and purified by ion exchange chromatogra-
phy. The resulting product was multimeric, and was>95% pure, as judged by 15% SDS-PAGE
electrophoresis. Endotoxin concentrations were estimated at 250 EU/mg (Lonza LAL QCL-
1000 assay).
Assessment of efficacy of a S. aureus SrtA vaccine
Female BALB/c mice were housed in groups of 8. At 7 weeks old, mice received an intramuscu-
lar injection with 109 i.u. human adenovirus 5 (AdHu5) expressing either SrtA, or no antigen,
followed 8 weeks later by 20 μg SrtA protein (protein preparation reference IMX501) per
mouse in AbISCO-100 (Isconova, Sweden, now acquired by Novavax, USA) or AbISCO-100
alone. At intervals, venous blood samples were taken from all animals for immune assays. Two
weeks after the last immunisation mice were inoculated in the tail vein with 0.1 ml (~107 CFU)
bacterial suspension, as described above. The mice were observed daily throughout the course
of the experiment, with humane end-points as described above. Fifteen days post infection
mice were sacrificed. The kidneys were harvested and processed as described above.
Assessment of Vaccine Immunity: Luciferase ImmunoPrecipitation
System (LIPS)
A Luciferase ImmunoPrecipitation System (LIPS) assay was used to detect specific serum anti-
S. aureus Sortase A antibodies as described [23]. Briefly, serially diluted serum was incubated
with Renilla luciferase-Sortase A fusion protein. The mix was added to filter plates loaded with
A/G beads (Thermo Fisher). After incubation and subsequent washings, chemoluminescence
was measured in a Luminometer (VarioSkan Flash, Thermo Fisher) after adding substrate
(Renilla luciferase assay system, Promega UK Ltd.). Log transformation was applied to lumi-
nescence data prior to statistical analysis. Specific luminescence was generated by subtracting
the assay background, which was considered to be the luminescence observed in the absence of
any sera. The assay limit of detection was considered to be four standard deviations above the
specific luminescence in the control groups.
Assessment of Vaccine Immunity: IFN-γ ELISpot
Individual peripheral blood samples were treated with ACK lysis buffer to remove red cells
prior to stimulation with a pool of 20-mer peptides overlapping by 10, spanning amino acids
57–206 of SrtA at a final concentration of 2 μg/ml in the presence of homologous splenocytes
(5x106 cells/ml), on High Protein Binding Immobilon-P membrane plates (MAIPS4510, Milli-
pore) coated with 5 mg/ml anti-mouse IFN- γ (AN18, Mabtech). After 18–20 hours incubation,
IFN- γ spot forming cells (SFC) were visualised by staining membranes with anti-mouse IFN-γ
biotin (1 μg/ml, R4-6A2, Mabtech) followed by streptavidin-Alkaline Phosphatase (1 μg/ml,
Mabtech) and development with AP conjugate substrate kit (BioRad, UK). Number of SFC
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were counted with an ELISpot reader (AID, Germany). Log SFC was used in statistical analysis
because of the approximate log-normal distribution of ELISpot counts in the animals [20].
MRI scanning
Kidneys were removed from infected mice and fixed in 4% PFA (Alfa Aesar, UK). We found
kidneys could be stored for long periods of time (up to 12 months tested) before imaging with
no detrimental effect. Kidneys were removed from PFA and soaked in a gadolinium-based con-
trast agent (Omniscan, GE Healthcare) at a concentration of 0.5 mmol/ml for 24 hours, then
mounted in a 28 mm glass tube and embedded in 1% agarose (Iberose, Web scientific, UK)
containing 2mM gadolinium contrast agent.
The imaging sequence we routinely use in our lab for MR microscopy of fixed tissues and
mouse embryos is based on a gradient echo pulse sequence, which generates a mixture of T1-
(due to a high flip-angle of 60° and a tissue-dependent Gd-uptake) and T2-contrast (long
echo time of 10ms) [24]. In addition, the Gd helps to bring down the T1 times, allowing for
shorter repetition times, and thus for shorter scan times. In particular, allowing for the data to
be acquired in unattended overnight runs greatly maximises the usage of an (expensive) pre-
clinical MR-system. While it was not specifically optimized for the detection of abscess in kid-
neys, the first test experiments yielded excellent resolution and contrast, demonstrating the
applicability of our MRI technique to successfully differentiate between healthy kidney tissues
and abscess.
Imaging experiments were carried out on a 9.4 T (400 MHz) MR system (Varian Inc., Palo
Alto, USA) comprising a horizontal magnet (bore size 210 mm), a VNMRS Direct DriveTM
console and an actively shielded gradient system (1000 mT/m, rise time 130 msec, od 115 mm,
id 60 mm). A quadrature-driven birdcage RF-coil (Rapid Biomedical, Rimpar, Germany) was
used for transmitting / receiving the MR signals. The MRI sequence was carried out essentially
as previously described [25], using a fast spoiled 3D gradient echo sequence with T1-weighting
(TE/TR = 10/ 30ms; flip-angle: 60°, matrix size 1408x608x608. field-of-view: 50x26x26mm,
sagittal orientation, total scan time: 12.25h).
Image analysis
Images were analysed using Amira software version 5.6 (FEI Visualisation Sciences Group).
This software reconstructs 2D images from the 3DMRI in any plane, allowing the comparison
with histological analysis conducted on the same tissue. Abscesses were identified visually by
operators reviewing the MRI images simultaneously in three views (xy, xz, yz) by scrolling
through ‘movie’ style, and then reviewing suspect areas. Criteria used to identify suspect areas
include (i) loss of normal renal architecture around the lesion (ii) an area of altered density
identified by histological comparison to reflect an abscess (iii) areas of segmental abnormality,
suggestive of vascular infarction. These latter were noted, but were not considered to be part of
abscess formation. A supplementary protocol provides additional details. Abscess volume was
estimated using the label field tool in Amira software which allows the selection of abscesses
from the MR image. The material statistics tool was applied to the labelled data which then cal-
culates the volume of all labelled areas. Abscess identification and size estimation were mea-
sured by one or two operators independently, blinded to the treatments associated with the
kidney studied.
Histological analysis
Subsequent to MR scan, kidneys were removed from agar and stored in PFA. Following embed-
ding in wax, three 5μM sections were taken through the long (sagittal) axis of each kidney at
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approximately 15%, 35% and 50% renal thickness and stained with haematoxylin and eosin
staining in the Oxford Centre for Histological Research (OCHRE), John Radcliffe Hospital,
Oxford.
Statistical analysis
Data on renal bacterial load was analysed for effect of vaccination by means of a t-test after a
log transformation of count data. To assess correlation between abscess areas, estimated by his-
tology, and abscess volumes estimated by MRI, Spearman’s r was computed. GraphPad Prism
v 5.04 (GraphPad Software, Inc.) was used for all computations.
Results
Mice were inoculated with 107 CFU S. aureus and were culled at days 3, 7 and 10 to harvest kid-
neys. One mouse scheduled for culling at day 10 had reached the pre-defined humane end-
point of the experiment on day 7 and was therefore culled and used in analysis for the day 7
time point.
MR imaging technique is able to detect and quantify abscess in murine
kidney
We were able to image up to 32 kidneys in a single MRI run in an agar tube (Fig 1), yielding
images at high spatial resolution (25.4 x 25.4 x 24.4μm) which afforded excellent definition of
renal cortex, medulla, and collection systems (S1 Video, which shows a typical set of normal
kidneys). Comparison of images obtained three days after infection (S2 Video) revealed obvi-
ous focal lesions, localised in the renal cortex. At later time points, these focal lesions increased
in size (S3 Video, showing lesions at 7 and 10 days).
We developed a standardised technique for identifying and quantitating these lesions,
which appeared compatible with S. aureus abscesses (S1 File). The technique relied on exami-
nation of MRI series, rather than single sections. Amira image analysis software was used to
assist with detection and marking of lesion margins, and to compute their sizes. Two observers
with no previous background in imaging were trained.
Subsequently, a 16 kidney test data set (S1–S3 Videos), consisting of 4 kidneys from each of
four time points (uninfected, 3, 7, 10 days post infection), was assembled and scored indepen-
dently, blind to group membership, by the two independent observers. Importantly, when the
infected kidneys were analysed and compared blindly by two observers, there was a strong pos-
itive correlation in the abscess volumes as calculated by each observer (Pearson’s correlation
coefficient = 0.915, p<0.005), Fig 2. We concluded the process of reading MRI scans was
reproducible.
Validation of MRI technique by subsequent histology. Since MRI is non-destructive for
the organs examined, we were able to recover organs post-scan and perform histological exam-
ination to perform MRI:histological correlation on individual organs. In initial inspection,
abscesses appeared readily detectable by both techniques, as illustrated in Fig 3. We obtained
histology on the test set of 16 kidneys, each with three sections per kidney, and compared these
with analysis of MRI images, obtained prior to histologist. Blinded examination by an expert
histopathologist (ES) noted 100% concordance between the putative abscesses noted in previ-
ous blinded MRI analysis. Importantly, no abscesses were detected by histology which were not
also detected by MRI. Histology did, however, identify subtle features specific to infected (as
opposed to control) kidneys, including an increase in intra-vessel neutrophils numbers in
regions distant to abscesses (Fig 4). We concluded that over the time period 3 to 10 days post
infection, MRI appears to be highly sensitive for the detection of S. aureus abscesses.
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Comparing multiple slice strategies to analyse volume of abscesses. A key decision in
histological analysis is the number of sections to be examined; higher numbers increase sensi-
tivity but also increase cost and labour. We considered the likely performance of MRI based vs.
histological detection and quantitation of abscesses 3 to 10 days post infection. In view of the
high sensitivity of MRI for the detection of abscesses, an ‘electronic histology’ approach was
adopted whereby ‘electronic sections’ were cut from a ‘block’ represented by the MRI image.
Fig 1. Scanning fixed organs after agar embedding. Up to thirty-two paraformaldehyde-fixed kidneys can
be placed in eight layers of four kidneys, and embedded in agarose containing the contrast agent. The tube is
then subjected to MR imaging.
doi:10.1371/journal.pone.0154705.g001
Fig 2. Inter-observer variability. Two observers were trained to use the MRI technique. After training, they
were tested independently on a 16 kidney test data set. The total volume of abscesses in each kidney
estimated by both observers is shown.
doi:10.1371/journal.pone.0154705.g002
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Four slicing strategies, taking 1,3,5 or 10 sections through the long axis of each kidney were
considered, specifically: 1 Slice at 50%; 3 Slices: 25, 50, and 75%; 5 Slices: 10, 30, 50, 70, and
90%; 10 Slices: 5, 15, 25, 35, 45, 55, 65, 75, 85, and 95% of the way through the short axis of the
kidney. The average area of abscesses detected in ‘electronic sections’ were compared relative
to those in the 3DMRI image.
A spherical abscess with radius r has volume proportional to r3, while a section through its
centre is expected to have area proportional to r2. Plotting log (volume) against log (estimated
area) is therefore expected to yield a linear relationship, if the section(s) are sufficiently close to
the centre of the abscess to approximate the true r. Therefore, as the number of sections rises,
the correlation with true abscess volume is expected to improve. A worst case scenario occurs
when the abscess is not included in a section at all. Results demonstrated that this expected
relationship was observed (Fig 5).
The electronic sectioning technique shows that a single section misses abscesses frequently
(4/12 abscesses, 33%), with 1/12 being missed by a three section technique (Fig 5A). As would
be expected, correlation between histological and true abscess volume improved as section
number rose, with five and ten section strategies offering high correlations with true abscess
size (Fig 5C and 5D). We concluded that the MRI technique allowed quantification of abscess
volumes.
Comparison of bacterial recovery with abscess formation. Analysis of a cohort of mice
infected with the same inoculum showed detected abscess number (as assessed by MRI) to
increase over time course (Fig 6A). This was also true of abscess volume (Fig 6B). By 10 days, the
abscess(es) occupied a substantial part of the renal volume (Fig 6, panel B). This observation is
supported by published work which reported abscess diameter estimated from histological
Fig 3. Staphylococcal abscess formation following intravenous infection of 107 CFU S. aureus in
mice. Kidneys were harvested at different time points post infection. Shown are pairs of images of the same
kidney section, with the left hand section (A,C,E,G) obtained by histological sectioning of kidneys which has
previously undergone MRmicroscopy (B,D,F,H). A,B show results at 3 days post infection (d.p.i), C,D at 7 d.
p.i, E,F at 10 d.p.i. G and H show images obtained frommice injected with PBS as a negative control. Circled
regions indicate abscesses. A scale bar is provided.
doi:10.1371/journal.pone.0154705.g003
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sectioning[10]. By contrast, bacterial recovery did not increase over time after day 3 (Fig 6, panel
C). Previous experiments conducted using this challenge model show that there is a positive cor-
relation between CFU recovery in the left vs the right kidney of each mouse [26]We concluded
that MRI imaging revealed information not discerned frommicrobiological quantification.
Evaluation of SrtA vaccine
The use of the technique was illustrated in a study of vaccination against Sortase A (SrtA) [10].
Balb/c mice were vaccinated with adenovirus Hu5 expressing either no exogenous antigen
(control) or SrtA, followed by a booster injection with SrtA protein or a vehicle control. This
regime (Fig 7A) has previously been used to generate high titres of antibodies against malaria
proteins[21]. The vaccine was immunogenic, generating specific antibody responses and weak
interferon γ producing T-cells (Fig 7B and 7C). Protective efficacy of the vaccine regime was
evaluated by a bacterial challenge. Symptoms scores were assessed daily. One mouse in Group
2 was culled on Day 12 post challenge (day 83 of the experiment) as it had reached the humane
endpoint. 7Renal bacterial counts were assessed at day 15. There was no significant difference
Fig 4. Histological changes distant frommacroscopic abscesses. Kidneys were fixed in PFA at various
time points after either mock infection (A) or with 107 CFU S. aureus (B-D). A scale bar is provided.
doi:10.1371/journal.pone.0154705.g004
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in bacterial counts between groups (Fig 7, panel D) (ANOVA, p = 0.47), with observed counts
similar to those seen at earlier time points in this model (Fig 6C). MRI scanning detected exten-
sive abscess formation in all groups (S4 Video; Fig 7E). Total abscess volume did not differ by
vaccine group at this time point (Fig 7F) (ANOVA on log abscess volume, p = 0.54). There was
no significant correlation between bacterial load and abscess volume between kidneys (r = 0.11
(95% CI -0.33–0.51)). We concluded the vaccine regime tested was not effective in the preven-
tion of abscess formation following intravenous challenge, and that the MRI technique detected
abscess expansion not detected using count-based approaches.
Discussion
The aim of this study was to establish and validate an MR screening method to quantify abscess
size in murine kidneys after challenge with S. aureus. Using high-resolution MRI (near-isotro-
pic voxel size ~ 25μm), we were able to show that, for abscesses 3 days or later post infection,
there is an excellent correlation between histopathological abscess quantification and MRI
appearances. Although unable to detect single cells (about 10 cells of about 8 μm diameter
would be expected per voxel), independent review by a pathologist indicated that the estimates
of abscess formation recovered fromMR image analysis was similar to that obtained histologi-
cally. There was also a very high level of inter-observer concordance (r = 0.9 for correlation
between estimated abscess volumes between two observers). Unlike histological analysis, the
entire kidney is imaged; simulation showed that this complete reconstruction allowed more
accurate estimation of abscess size than histology, unless 5 or more sections were taken through
the kidney.
It has been reported that there is a poor correlation between S. aureus abscess size and bacte-
rial recovery[10]. The MRI technique confirms this: over the course of ten days, abscesses grew
but bacterial recovery in the partner kidney changed little. Thus, abscess size confers additional
Fig 5. A simulation of various sectioning strategies was performed using the data obtained fromMRI
scanning. A comparison of the total abscess volume calculated from each kidney and the estimation
achieved by an average of abscess areas in sections is depicted for each slicing strategy. (A): 1 slice
estimation, (B) 3 slice estimation, (C) 5 slice estimation, (D) 10 slice estimation.
doi:10.1371/journal.pone.0154705.g005
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information relative to bacterial recovery, and highlights the need for a technique that is able to
reliably quantify abscess size.
A limitation of the MRI approach is that it does not reveal information on the distribution
of cell type(s), bacterial pseudocapsule, or the expression of cell surface or bacterial molecules,
although all of which could be monitored by immunohistochemistry. The two approaches are
not mutually exclusive, however, histology can be performed following MRI, either on a pre-
specified protocol, or targeting areas of interest identified by MRI. While the ex vivo MRI tech-
nique precludes investigation of abscess formation serially in the same mouse, it provides supe-
rior resolution compared to any in vivoMR imaging approach. Use of MRI to detect S. aureus
in vivo has been reported in various models of murine infection [15, 27, 28]. However, future
work will explore whether or not this technique can also provide sufficient spatial resolution
and contrast in vivo to allow for accurate assessment of abscess development in murine renal
tissue, allowing sequential monitoring of disease progression [29].
Having established and validated this new technique, its use was illustrated in a study of vac-
cine efficacy. SrtA, a bacterial enzyme required for abscess formation, was studied[10]. The
vaccination regime, which generated antibodies against SrtA, offered no protection in this
challenge model: neither the bacterial recovery from the kidneys nor the MRI analysis of the
abscess volumes showed any significant difference between the vaccinated and the control
group. Explanations might include lack of access of the antibodies to the SrtA enzyme, or lack
of function of the antibodies generated.
Fig 6. Quantification of abscess growth using MRI. Female Balb/c mice were injected intravenously with
107 CFU S. aureusNewman. Kidneys were recovered at varying days post infection (DPI). A: The right
kidney was fixed in paraformaldehyde, and processed for subsequent MRI analysis. Individual abscess in
each kidney (A) and the total volume of abscess present per kidney (B) were calculated. Both the median
volume of abscesses detected (A), and the total volume of abscesses (B) increase significantly over time, but
(C) bacterial recovery in the left kidney changed little between 3 and 10 days post infection (C,D). Where no
abscesses were detected, abscess volume was considered to be 1mm3 (Panel B), and when no bacteria
were isolated, 1 CFU/g is plotted (Panel C). ** denotes p<0.01, * denotes p<0.05 by Mann-Whitney test.
doi:10.1371/journal.pone.0154705.g006
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To conclude, the technique described provides an important tool for enumerating and mon-
itoring abscess growth, and is suitable for use in preclinical vaccination development in mice
challenged with intravenous S. aureus.
Supporting Information
S1 File. Supplementary protocol. This describes the technique used for analysis of the MRI
images.
(DOCX)
S1 Fig. Layout of samples in S4 Video. This depicts the layout of kidneys in the S4 Video.
(DOCX)
S1 Table. Scoring system used for mice challenged intravenously with S. aureus. This
describes the scoring system for mice following intravenous challenge.
(DOCX)
S2 Table. Group assignations in S4 Video.
(DOCX)
S1 Video. MRI video showing a typical set of normal kidneys. The video is of kidneys recon-
structed in one plane. The video goes from the top to the bottom of the agar tube containing
kidneys which was used for analysis.
(MP4)
Fig 7. Immunogenicity of Sortase A vaccine regimes.Mice were immunised with either a control regime
comprising AdHu5 (Human adenovirus 5) expressing no transgene (Regime 1), or with AdHu5 expressing
SrtA (Regime 2), or with the same vector followed 8 weeks later by a SrtA protein boost (Regime 3) (A). (B)
Serological assay was performed on serum taken from immunised mice and specific antibody concentration
to SrtA is presented in arbitrary luciferase units, calculated as log10(Luciferase units- Background) in the LIPS
assay used (C) An ELISPOT was performed from blood taken from immunized mice seven days on day 63
post adenoviral priming, or day 7 post protein boost. The difference between groups was not statistically
significant. 15 days after infection, (D) bacterial recovery from the left kidney, and renal abscess formation (E,
F) assessed by the MR technique were determined.
doi:10.1371/journal.pone.0154705.g007
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S2 Video. MRI video showing images of kidneys obtained three days after infection. The
video is of kidneys reconstructed in one plane. The video goes from the top to the bottom of
the agar tube containing kidneys which was used for analysis.
(MP4)
S3 Video. MRI video showing images of kidneys obtained seven- ten days after infection.
The video is of kidneys reconstructed in one plane. The video goes from the top to the bottom
of the agar tube containing kidneys which was used for analysis.
(MP4)
S4 Video. MRI video showing images of kidneys from the sortase A vaccination experi-
ment. The video is of kidneys reconstructed in one plane. The video goes from the top to the
bottom of the agar tube containing kidneys which was used for analysis. The groups are as
shown in Fig 7, with the addition of three non-infection control kidneys, designated C. For
example, in row 8 the kidneys are laid out as in S1 Fig. The group assignations are shown in S2
Table.
(MP4)
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